Showing results (681-690 of 725) with videos related to
Sort By:
Pageof 73
Elife|June 28, 2021
Structure and mechanistic features of the prokaryotic minimal RNase PRebecca Feyh, Nadine B Waeber, Simone Prinz, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|July 9, 1999
Aortic connexin43 is decreased during hypertension induced by inhibition of nitric oxide synthaseJ A Haefliger, P Meda, A Formenton, et al.Journal of Cardiovascular Pharmacology|June 1, 1995
Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin IN Inglessis, J Nussberger, M Hagmann, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 1, 1992
Arterial dilatory reserve in congestive heart failureR Zelis, D Hayoz, H Drexler, et al.The Journal of Clinical Endocrinology and Metabolism|December 12, 2001
NPY regulates catecholamine secretion from human adrenal chromaffin cellsC Cavadas, A P Silva, F Mosimann, et al.Journal of Hypertension|October 11, 2001
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and goutG Würzner, J C Gerster, A Chiolero, et al.Journal of Cardiovascular Pharmacology|June 1, 1995
Comparison of the oral angiotensin II receptor antagonist UP 269-6 or enalapril 20 mg on blood pressure and neurohormonal effects in salt-deplete manM McIntyre, R J MacFadyen, P A Meredith, et al.Journal of Hypertension|April 29, 1998
Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patientsA Pechère-Bertschi, J Nussberger, L Decosterd, et al.Journal of Cardiovascular Pharmacology|September 1, 1991
Baroreflex and atrial natriuretic factor concentration correlate with myocardial infarct size and predict early death in rabbits: implications for drug studiesR P Hof, Y Takiguchi, J Nussberger, et al.The Journal of Clinical Investigation|December 19, 2001
Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2C Pellieux, A Foletti, G Peduto, et al.Pageof 73